Induced pluripotent stem cell technology and stem cell therapy for diabetes (review)

Experimental and Therapeutic Medicine

Volumn 2, Issue 1, 2011, Pages 3-7

  Drummond, Robert J ^a   Kunath, Tilo ^a   Joseph Mee, P ^a   Ross, James A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cellular therapeutics; Clinical potential; Diabetes; Stem cells

Indexed keywords

INSULIN;

CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL NUCLEUS TRANSPLANTATION; DIABETES MELLITUS; FERTILIZATION IN VITRO; GENE EXPRESSION; HUMAN; INSULIN RELEASE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PANCREAS ISLET BETA CELL; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; REVIEW; STEM CELL TRANSPLANTATION;

EID: 78751631371     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2010.173     Document Type: Review

References (44)

1. Kroon E, Martinson LA, Kadoya K, et al: Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 26: 443-452, 2008.
2. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al: Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147, 1998.
3. Devolder K: Creating and sacrificing embryos for stem cells. J Med Ethics 31: 366-370, 2005.
4. Tzukerman M, Rosenberg T, Ravel Y, Reiter I, Coleman R and Skorecki K: An experimental platform for studying growth and invasiveness of tumor cells within teratomas derived from human embryonic stem cells. Proc Natl Acad Sci USA 100: 13507-13512, 2003.
5. Drukker M, Katchman H, Katz G, et al: Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 24: 221-229, 2006.
6. Taylor CJ, Bolton EM, Pocock S, Sharples LD, Pedersen RAand Bradley JA: Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLAmatching. Lancet 366: 2019-2025, 2005.
7. Briggs R and King TJ: Transplantation of living nuclei from blastula cells into enucleated frogs' eggs. Proc Natl Acad Sci USA 38: 455-463, 1952.
8. Wilmut I, Schnieke AE, McWhir J, Kind AJ and Campbell KH: Viable offspring derived from fetal and adult mammalian cells. Nature 385: 810-813, 1997.
9. Gurdon JB and Byrne JA: The first half-century of nuclear transplantation. Proc Natl Acad Sci USA 100: 8048-8052, 2003.
10. Wakayama S, Jakt ML, Suzuki M, et al: Equivalency of nuclear transfer-derived embryonic stem cells to those derived from fertilized mouse blastocysts. Stem Cells 24: 2023-2033, 2006.
11. Cowan CA, Atienza J, Melton DA and Eggan K: Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309: 1369-1373, 2005.
12. Matsumura H, Tada M, Otsuji T, et al: Targeted chromosome elimination from ES-somatic hybrid cells. Nat Methods 4: 23-25, 2007.
13. Matsumura H and Tada T: Cell fusion-mediated nuclear reprogramming of somatic cells. Reprod Biomed Online 16: 51-56, 2008.
14. Silva J, Chambers I, Pollard S and Smith A: Nanog promotes transfer of pluripotency after cell fusion. Nature 441: 997-1001, 2006.
15. Takahashi K and Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676, 2006.
16. Chin MH, Mason MJ, Xie W, et al: Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5: 111-123, 2009.
17. Ghosh Z, Wilson KD, Wu Y, Hu S, Quertermous T and Wu JC: Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS One 5: e8975, 2010.
18. Meissner A, Wernig Mand Jaenisch R: Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol 25: 1177-1181, 2007.
19. Okita K, Ichisaka T and Yamanaka S: Generation of germline-competent induced pluripotent stem cells. Nature 448: 313-317, 2007.
20. Wernig M, Meissner A, Foreman R, et al: In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448: 318-324, 2007.
21. Takahashi K, Tanabe K, Ohnuki M, et al: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872, 2007.
22. Park IH, Zhao R, West JA, et al: Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451: 141-146, 2008.
23. Yu J, Vodyanik MA, Smuga-Otto K, et al: Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920, 2007.
24. Huangfu D, Osafune K, Maehr R, et al: Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 26: 1269-1275, 2008.
25. Kim JB, Sebastiano V, Wu G, et al: Oct4-induced pluripotency in adult neural stem cells. Cell 136: 411-419, 2009.
26. Yamanaka S: Afresh look at iPS cells. Cell 137: 13-17, 2009.
27. Okita K, Nakagawa M, Hyenjong H, Ichisaka T and Yamanaka S: Generation of mouse induced pluripotent stem cells without viral vectors. Science 322: 949-953, 2008.
28. Soldner F, Hockemeyer D, Beard C, et al: Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136: 964-977, 2009.
29. Woltjen K, Michael IP, Mohseni P, et al: piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458: 766-770, 2009.
30. Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P and Woltjen K: Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458: 771-775, 2009.
31. Zhou H, Wu S, Joo JY, et al: Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4: 381-384, 2009.
32. Yu J, Hu K, Smuga-Otto K, et al: Human induced pluripotent stem cells free of vector and transgene sequences. Science 324: 797-801, 2009.
33. Shi Y, Desponts C, Do JT, Hahm HS, Scholer HR and Ding S: Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3: 568-574, 2008.
34. Shi Y, Do JT, Desponts C, Hahm HS, Scholer HR and Ding S: Acombined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2: 525-528, 2008.
35. Li W, Wei W, Zhu S, et al: Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell 4: 16-19, 2009.
36. Soria B, Roche E, Berna G, Leon-Quinto T, Reig JA and Martin F: Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 49: 157-162, 2000.
37. Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R and McKay R: Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292: 1389-1394, 2001.
38. Kubo A, Shinozaki K, Shannon JM, et al: Development of definitive endoderm from embryonic stem cells in culture. Development 131: 1651-1662, 2004.
39. D'Amour KA, Agulnick AD, Eliazer S, Kelly OG, Kroon E and Baetge EE: Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 23: 1534-1541, 2005.
40. D'Amour KA, Bang AG, Eliazer S, et al: Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 24: 1392-1401, 2006.
41. Jiang J, Au M, Lu K, et al: Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells 25: 1940-1953, 2007.
42. Tateishi K, He J, Taranova O, Liang G, D'Alessio ACand Zhang Y: Generation of insulin-secreting islet-like clusters from human skin fibroblasts. J Biol Chem 283: 31601-31607, 2008.
43. Zhang D, Jiang W, Liu M, et al: Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res 19: 429-438, 2009.
44. Maehr R, Chen S, Snitow M, et al: Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci USA 106: 15768-15773, 2009.